Targeted radiation for thymoma spread to the lung lining
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests a newer way of giving radiation therapy to people with thymoma that has spread to the lining of the lung (pleura). The goal is to see if it can control the cancer with fewer side effects than standard treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of thymoma (types AB, B1-B3, or C).
- The thymoma has spread to the lining of the lung (pleura) and can be measured on scans.
- You are 18 to 74 years old.
- You are physically active and able to care for yourself (ECOG score 0 or 1).
- You have not had radiation to the chest, or immunotherapy or biological therapy in the past.
- Your blood counts, kidney, and liver function are within acceptable ranges.
- You have not had other cancers recently (except for some skin cancers or early cervical cancer).
- You are not pregnant, breastfeeding, or planning to become pregnant during the trial.
- You do not have serious heart problems, uncontrolled infections, or other major illnesses.
- You are not participating in another clinical trial at this time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter course of radiation (hypofractionated radiotherapy) for people with thymoma or thymic carcinoma. It aims to see if fewer, larger doses of radiation are safe and effective for treating these tumors.
This trial combines surgery (burning away the tumor) with heated chemotherapy given directly into the chest to treat thymus gland tumors that have spread to the lining of the lung or chest wall. The goal is to remove the visible tumor and wash the area with heated chemo to help delay or prevent it from coming back.
This Phase 2 study tests a precise type of chest radiation that targets cancer in the lung lining (pleura) while trying to protect healthy lungs and organs. It may help people with thymic cancer that has spread to the pleura, including cases that return after prior treatment.
This trial tests giving radiation therapy before surgery for a type of thymus gland tumor (thymoma) that has grown into nearby tissues but has not been treated yet. The goal is to see if this approach can make the tumor removable and improve outcomes.
This trial tests a shorter course of radiation therapy (fewer, larger doses) given after surgery for thymic tumors. The goal is to reduce the chance of the tumor returning while keeping side effects manageable.
This trial tests a shorter course of radiation therapy (hypofractionated) after surgery for people with Stage II or III thymoma or thymic cancer. The goal is to prevent the tumor from coming back.
Hear when a new Thymoma and Thymic Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.